Gut and Breast Milk Microbiota and Their Role in the Development of the Immune Function

Current Pediatrics Reports

Volumn 2, Issue 3, 2014, Pages 218-226

  Baldassarre, Maria Elisabetta ^a   Bellantuono, Loredana ^a   Mastromarino, Paola ^b   Miccheli, Alfredo ^b   Fanelli, Margherita ^a   Laforgia, Nicola ^a  

^a UNIVERSITY OF BARI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Breast milk microbiota; Gut; Gut microbiota; Immune function; Newborns

Indexed keywords

EID: 85060280838     PISSN: None     EISSN: 21674841     Source Type: Journal    
DOI: 10.1007/s40124-014-0051-y     Document Type: Article

References (55)

1. Rautava S, Walker WA. Immunophysiology and nutrition of the gut. Nutrition in Pediatrics. 4th ed. 2008.
2. •• Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012;336:1268–73. Advances in understanding of the interactions between resident microbes and the immune system and the implications of these findings for human health.
3. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature. 2003;422:522–6. DOI: 10.1038/nature01520
4. Diebel LN, Liberati DM, Baylor AE III, et al. The pivotal role of tumor necrosis factor-alpha in signaling apoptosis in intestinal epithelial cells under shock conditions. J Trauma. 2005;58:995–1001. DOI: 10.1097/01.TA.0000162727.30897.C8
5. Planchon SM, Martins CA, Guerrant RL, Roche JK. Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol. 1994;153:5730–9.
6. Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology. 2004;126:1054–70. DOI: 10.1053/j.gastro.2004.01.007
7. Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, Glickman JN, Glimcher LH. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007;131:33–45. DOI: 10.1016/j.cell.2007.08.017
8. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328:228–31. DOI: 10.1126/science.1179721
9. • Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, Flavell RA. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745–57. The importance of the gut microbiota in the pathogenesis of various autoimmune disorders that manifest outside of the gastrointestinal tract.
10. Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol. 2011;2:94. DOI: 10.3389/fphys.2011.00094
11. • Bercik P, Collins SM, Verdu EF. Microbes and the gut-brain axis. Neurogastroenterol Motil. 2012;24:405–13. The current evidence for a role of bacteria (commensals, probiotics, and pathogens) as key modulators of gut-brain communication.
12. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136:2003–14. DOI: 10.1053/j.gastro.2009.01.075
13. •• Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108:16050–5. The important role of bacteria in the bidirectional communication of the gut-brain axis. Certain organisms may prove to be useful therapeutic adjuncts in stress-related disorders such as anxiety and depression.
14. Sütas Y, Hurme M, Isolauri E. Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. Scand J Immunol. 1996;43:687–9. DOI: 10.1046/j.1365-3083.1996.d01-258.x
15. Sütas Y, Soppi E, Korhonen H, Syväoja EL, Saxelin M, Rokka T, Isolauri E. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. J Allergy Clin Immunol. 1996;98:216–24. DOI: 10.1016/S0091-6749(96)70245-2
16. Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 2010;298(6):G807–19.
17. •• Ashida H, Ogawa M, Kim M, Mimuro H, Sasakawa C. Bacteria and host interactions in the gut epithelial barrier. Nat Chem Biol. 2011;8:36-45. An overview of the components of the mucosal barrier and the bacterial stratagems that circumvent these barriers with particular emphasis on the roles of bacterial effector proteins.
18. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol. 2010;10:735–44.
19. Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M, Brandi G, Eberl G, Snel J, Kelly D, Cerf-Bensussan N. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 2009;31:677–89. DOI: 10.1016/j.immuni.2009.08.020
20. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485–98. DOI: 10.1016/j.cell.2009.09.033
21. Abraham C, Cho JH. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2009;60:97–110. DOI: 10.1146/annurev.med.60.051407.123757
22. • Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4615-22. The intestinal microbiota profoundly impacts the balance between pro- and antiinflammatory immune responses during experimental autoimmune encephalomyelitis and suggest that modulation of gut bacteria may provide therapeutic targets for extraintestinal inflammatory diseases such as Multiple Sclerosis.
23. Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, Littman DR, Benoist C, Mathis D. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32:815–27. DOI: 10.1016/j.immuni.2010.06.001
24. Ohsugi T, Kurosawa T. Increased incidence of diabetes mellitus in specific pathogen-eliminated offspring produced by embryo transfer in NOD mice with low incidence of the disease. Lab Anim Sci. 1994;44:386–8.
25. Leiter E. The role of microorganisms in non-infectious disease, R. d. Vries, I. Cohen, and J. J. v. Rood, eds. Berlin: Springer Verlag. 1990;39–55.
26. Sjögren YM, Jenmalm MC, Böttcher MF, Björkstén B, Sverremark-Ekström E. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy. 2009;39:518–26. DOI: 10.1111/j.1365-2222.2008.03156.x
27. Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun. 2005;73:30–8. DOI: 10.1128/IAI.73.1.30-38.2005
28. Schumann Al, Nutten S, Donnicola D, Comelli EM, Mansourian R, Cherbut C, Corthesy-Theulaz I, Garcia-Rodenas C. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics. 2005;23:235–45. DOI: 10.1152/physiolgenomics.00057.2005
29. Kopp MV, Goldstein M, Dietschek A, Sofke J, Heinzmann A, Urbanek R. Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo ef- fects in supplemented mothers and their neonates. Clin Exp Allergy. 2008;38:602–10. DOI: 10.1111/j.1365-2222.2007.02911.x
30. Abrahamsson TR, Jakobsson T, Böttcher MF, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1174–80. DOI: 10.1016/j.jaci.2007.01.007
31. Wickens K, Black PN, Stanley TV. Probiotic study group. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122:788–94. DOI: 10.1016/j.jaci.2008.07.011
32. •• Rautava S, Luoto R, Salminen S, Isolauri E. Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol. 2012;9:565–76. The authors describe the current body of knowledge regarding perinatal microbial contact, initial intestinal colonization and its association with human disease, as well as means of modulating early host-microbe interaction to reduce the risk of disease in the child.
33. Le Huërou-Luron I, Blat S, Boudry G. Breast- vs formula-feeding: impacts on the digestive tract and immediate and long-term health effects. Nutr Res Rev. 2010;23:23–36. DOI: 10.1017/S0954422410000065
34. Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res. 2007;61:2–8. DOI: 10.1203/01.pdr.0000250274.68571.18
35. Rautava S, Walker WA. Academy of Breastfeeding Medicine founder’s lecture 2008: breastfeeding–an extrauterine link between mother and child. Breastfeed Med. 2009;4:3–10. DOI: 10.1089/bfm.2009.0004
36. •• Thum C, Cookson AL, Otter DE, McNabb WC, Hodgkinson AJ, Dyer J, Roy NC. Can nutritional modulation of maternal intestinal microbiota influence the development of the infant gastrointestinal tract? J Nutr. 2012;142:1921–8. This review examines the manipulation of the maternal GIT microbiota composition through the use of probiotics and/or prebiotics and subsequent consequences for the health of the offspring.
37. •• Roduit C, Wohlgensinger J, Frei R, Bitter S, Bieli C, Loeliger S, Büchele G, Riedler J, Dalphin JC, Remes S, Roponen M, Pekkanen J, Kabesch M, Schaub B, von Mutius E, Braun-Fahrländer C, Lauener R; PASTURE Study Group. Prenatal animal contact and gene expression of innate immunity receptors at birth are associated with atopic dermatitis. J Allergy Clin Immunol. 2011;127:179–85, 185.e1. An innovative epidemiologic study that have indicated that maternal contact with farm animals, which presumably entails increased microbial contact during pregnancy, modulates fetal innate immune gene expression and protects the infants from development of dermatitis.
38. Conrad ML, Ferstl R, Teich R, Brand S, Blümer N, Yildirim AO, Patrascan CC, Hanuszkiewicz A, Akira S, Wagner H, Holst O, von Mutius E, Pfefferle PI, Kirschning CJ, Garn H, Renz H. Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78. J Exp Med. 2009;206:2869–77. DOI: 10.1084/jem.20090845
39. Rautava S, Lu L, Nanthakumar NN, Dubert-Ferrandon A, Walker WA. TGF-β2 induces maturation of immature human intestinal epithelial cells and inhibits inflammatory cytokine responses induced via the NF-κB pathway. J Pediatr Gastroenterol Nutr. 2012;54:630–8. DOI: 10.1097/MPG.0b013e31823e7c29
40. • Kaplan JL, Shi HN, Walker WA. The role of microbes in developmental immunologic programming. Pediatr Res 2011;69:465–72. Exposure to microbes before conception, during gestation, and in the neonatal period have profound effects on the developing immune system.
41. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh E. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118:511–21. DOI: 10.1542/peds.2005-2824
42. Adlerberth I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Paediatr. 2009;98:229–38. DOI: 10.1111/j.1651-2227.2008.01060.x
43. Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu L, Uauy R, Llanos A, Claud EC, Walker WA. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS ONE. 2011;6:e17776. DOI: 10.1371/journal.pone.0017776
44. Jiménez E, Marín ML, Martín R, Odriozola JM, Olivares M, Xaus J, Fernández L, Rodríguez JME, et al. Is meconium from healthy newborns actually sterile? Res Microbiol. 2008;159:187–93. DOI: 10.1016/j.resmic.2007.12.007
45. Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ, Kerr C, Hourihane J, Murray D, Fuligni F, Gueimonde M, Margolles A, De Bellis G, O’Toole PW, van Sinderen D, Marchesi JR, Ventura M. Diversity of bifidobacteria within the infant gut microbiota. PLoS One. 2012;7:e36957. DOI: 10.1371/journal.pone.0036957
46. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5:e177. DOI: 10.1371/journal.pbio.0050177
47. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, Welling GW. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30:61–7. DOI: 10.1097/00005176-200001000-00019
48. Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K, Klarczyk M, Schöpfer H, Böckler HM, Wells J. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr. 2005;40:36–42. DOI: 10.1097/00005176-200501000-00007
49. Collado MC, Delgado S, Maldonado A, Rodríguez JM. Assessment of the bacterial diversity of breast milk of healthy women by quantitative real-time PCR. Lett Appl Microbiol. 2009;48:523–8. DOI: 10.1111/j.1472-765X.2009.02567.x
50. Fernandez L, Langa S, Martín V, Maldonado A, Jiménez E, Martín R, Juan M, Rodríguez JM. The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res. 2013;69:1–10. DOI: 10.1016/j.phrs.2012.09.001
51. Gueimonde M, Sakata S, Kalliomäki M, Isolauri E, Benno Y, Salminen S. Effect of maternal consumption of Lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J Pediatr Gastroenterol Nutr. 2006;42:166–70. DOI: 10.1097/01.mpg.0000189346.25172.fd
52. Lahtinen SJ, Boyle RJ, Kivivuori S, Oppedisano F, Smith KR, Robins-Browne R, Salminen SJ, Tang ML. Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. J Allergy Clin Immunol. 2009;123:499–501. DOI: 10.1016/j.jaci.2008.11.034
53. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355–60. DOI: 10.1016/j.jaci.2012.09.003
54. Baldassarre ME, Cacciotti F, Miccheli A, Urbano F, Laforgia N, Mastromarino P. VSL#3 probiotic maternal supplementation affects breast milk composition and newborn faeces microbiota. Dig Liver Dis. 2012;44:S253. DOI: 10.1016/S1590-8658(12)60656-2
55. Vitali B, Cruciani F. Baldassarre ME, Capursi T, Spisni E, Maria Valerii MC, Candela M, Turroni S and Brigidi P. Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion. BMC Microbiol. 2012;12:236–40. DOI: 10.1186/1471-2180-12-236